您现在的位置: 首页> 研究主题> 次全切除

次全切除

次全切除的相关文献在1982年到2021年内共计76篇,主要集中在外科学、肿瘤学、临床医学 等领域,其中期刊论文70篇、会议论文1篇、专利文献837076篇;相关期刊62种,包括现代中西医结合杂志、基层医学论坛、临床医学等; 相关会议1种,包括第十届全国骨与关节损伤学术会议等;次全切除的相关文献由199位作者贡献,包括侯东旭、刘芳、张宇等。

次全切除—发文量

期刊论文>

论文:70 占比:0.01%

会议论文>

论文:1 占比:0.00%

专利文献>

论文:837076 占比:99.99%

总计:837147篇

次全切除—发文趋势图

次全切除

-研究学者

  • 侯东旭
  • 刘芳
  • 张宇
  • 方媛
  • 李敏娟
  • 李秀静
  • 杨涛
  • 梅静
  • 王朝阳
  • 薛锋
  • 期刊论文
  • 会议论文
  • 专利文献

搜索

排序:

年份

    • 田耀辉; 陈永汉; 贾林伟
    • 摘要: 目的:观察脑胶质瘤行显微镜下全切或次全切除术治疗的临床疗效与术后并发症率.方法:以我院接收的78例脑胶质瘤患者为对象展开研究,以随机数字法将研究对象均分成研究组39例以及参照组39例.给予参照组开颅手术治疗,给予研究组显微镜下全切或次全切除术治疗,评价临床疗效.结果:研究组(5.13%)并发症发生率低于参照组(23.08%),P<0.05;研究组术后MMSE评分及AVP水平均高于参照组,P<0.05.结论:采取显微镜下全切或次全切除术治疗脑胶质瘤的效果显著,可显著改善患者认知功能与脑脊液神经肽水平,同时还可降低相关并发症,有利于术后康复,值得采纳.
    • 张福寿; 李青松
    • 摘要: 目的 探讨结节性甲状腺肿次全切后左甲状腺素替代治疗有效时机.方法 以80例结节性甲状腺肿患者为研究对象,随机分为对照组和观察组,对照组术后2周进行左甲状腺素替代治疗,观察组术后次日开始替代治疗,比较两组促甲状腺激素水平及趋于稳定所需时间、并发症及生活质量.结果 观察组术后促甲状腺激素水平明显低于对照组,趋于稳定所需时间短于对照组(P<0.05);观察组焦虑/抑郁、疼痛/不舒服评分高于对照组,自我评价健康评分及并发症发生率低于对照组(P<0.05).结论 结节性甲状腺肿次全切术后早期给予左甲状腺素替代治疗,利于患者促甲状腺激素水平早期趋于稳定,减少并发症发生,提高生活质量.
    • 薛建利; 董军; 孔洋; 张纯; 程斌
    • 摘要: 目的 对颈前路椎体次全切除融合术(ACCF)与连续双节段双间隙颈前路椎间盘切除融合术(ACDF)术后患者影像学解剖参数、相关围手术期参数进行比较,了解两种术式术后患者颈椎影像学的变化及临床疗效的差异性.方法 回顾性纳入西安交通大学第二附属医院骨科 241 例连续双间隙颈椎间盘突出脊髓型颈椎病患者,ACDF 组51 例[男∶女=32∶19,平均年龄(56.3±29.4)岁];ACCF组47 例[男∶女=35∶12,平均年龄(49.1±22.8)岁].观察指标:性别比例、平均年龄、平均住院时间、平均手术时间、平均术中出血量;术前、术后 1 d、术后 6 个月、术后 1 年、术后 2 年的JOA评分和影像学观察指标.采用 SPSS 19.0 软件对上述指标进行统计学分析.结果 ACDF组患者较ACCF组有较短的手术时间、手术出血量和较短的住院时间;ACDF组患者较 ACCF组患者的术后JOA 评分无显著性差异;ACDF组患者较 ACCF组患者有着较佳的影像学指标.结论 在治疗连续双间隙颈椎间盘突出脊髓型颈椎病方面,ACDF较 ACCF的影像学观察所见疗效更佳.%Objective To compare the postoperative imaging anatomical parameters and the related perioperative parameters of continuous double-gap cervical spondylotic myelopathy patients who underwent anterior cervical disectomy and fusion (ACDF)or anterior cervical corpectomy and fusion (ACCF)and ACDF so as to learn about the clinical effects of the two methods.Methods We included 5 1 patients in ACDF group (male∶female ratio=32∶19;mean age 56.3±29.4 years),and 47 patients (male∶female ratio=35∶12;mean age 49.1±22.8 years)in ACCF group.We measured the sex ratio,mean age,average length of hospital stay,mean operative time, and average intraoperative blood loss in ACDF group and ACCF group.The patients were followed up at six months,1 year,and 2 years after operation.The JOA score and imaging parameters were recorded for statistical analysis by SPSS 19.0.Results Patients in ACDF group had shorter operative time,less operative bleeding and shorter hospitalization duration than those in ACCF group.There was no significant difference in postoperative JOA score between ACDF and ACCF group.Patients in ACDF group had better imaging indexes than those in ACCF group.Conclusion ACDF has better screening efficacy than ACCF in treatment of continuous double-gap cervical disc herniation of cervical spondylotic myelopathy.
    • 谭红娥
    • 摘要: 目的:探讨全子宫和次全子宫切除术对盆底功能的影响.方法:收集本院接受子宫切除术的患者,根据患者手术类型分为研究组(采取次全子宫切除术)和对照组(采取全子宫切除术).对比两组手术疾病类型;两组手术后相关指标;两组术后12月PFIQ-7盆腔功能障碍评分.结果:两组手术疾病类型比较无显著差异(P>0.05);两组手术时间及术中出血量比较有显著差异(P<0.05);两组手术后相关指标(术后肠蠕动恢复时间、术后12小时体温、术后首次下地时间)比较有显著差异(P<0.05);研究组和对照组术后12月PFIQ-7盆腔功能障碍评分分别为(4.26±0.16)分、(6.59±0.58)分,比较有显著差异(P<0.05),研究组明显优于对照组.结论:相对于全子宫,次全子宫切除术手术创伤少,术后恢复快,同时对盆底功能影响少.
    • 赵瑛; 王首杰; 赵海康
    • 摘要: 目的 评价胶质瘤次全切除后给予甲泼尼龙治疗瘤周水肿的临床疗效及安全性.方法 收集2015年6月至2016年1月95例胶质瘤次全切除病例,随机分为甲泼尼龙组(n=32)、地塞米松组(n=33)及对照组(n=30),术后前两组分别给予等效剂量的甲泼尼龙40 mg/次和地塞米松10 mg/次,每天2次静脉治疗(上午8:00、下午4:00),对照组仅应用脱水治疗.根据《颅内肿瘤周围水肿药物治疗专家共识(第1版)》,采用头颅MRI测算3组术后72 h、5d、14 d、28 d的水肿指数(EI).观察治疗过程中各组的不良反应情况.结果 对于胶质瘤次全切除术后瘤周水肿,在术后3~7天水肿产生高峰期,甲泼尼龙组术后5天的EI较地塞米松组减少,差异无统计学意义(P>0.05);甲泼尼龙组和地塞米松组术后14天的EI分别为2.58±1.02和3.67±1.71,差异有统计学意义(P=0.023),两组术后28天的EI分别为1.76±0.72和2.14±1.13,差异有统计学意义(P=0.01).地塞米松对内环境的影响和甲泼尼龙引起的消化道应激性反应各有劣势.结论 对于控制胶质瘤次全切除术后瘤周水肿,甲泼尼龙较地塞米松更有优势,但应积极预防激素本身引起的不良反应.%Objective To evaluate the clinical efficacy and safety of methylprednisolone for the treatment of peritumoral edema after glioma subtotal resection.Methods From Jun 2015 to Jan 2016,a total of 95 cases of glioma which underwent subtotal resection were selected and randomly divided into methylprednisolone group (n =32),dexamethasone group(n =33) and control group(n =30).After operation,methylprednisolone and dexamethasone groups were treated with equivalent dose of methylprodnisolone 40 mg and dexamethasone 10 mg and twice a day at 8:00 and 16:00.The control group was only applied with dehydration treatment.Based on consensus on the drug treatment of peritumoral brain edema (1st edition),the edema index (EI) values of each group were respectively tested by MRI at the different time points including 72 hours,5 days,14 days and 28 days after subtotal resection.The adverse reactions of these 3 groups were monitored during the treatment.Results During the peak period of edema which appeared from the 3rd to 7th days,although methylprednisolone was more effective to control the peritumoral edema comparing with dexamethasone,there was no obvious statistical difference (P>0.05).After 14 days,the EI values of methylprednisolone group and dexamethasone group were 2.58 ± 1.02 and 3.67± 1.71 respectively,and the difference was statistically significant (P=0.023).On the 28th day,the EI values were 1.76±0.72 and 2.14± 1.13 respectively,and difference was statistically significant (P=0.01).Both of these two groups had their own defect due to the adverse drugs reactions,dexamethasone could influence the internal environment and the methylprednisolone would cause gastrointestinal stress response.Conclusion With equivalent dose,methylprednisonone is more efficient to control peritumoral edema after subtotal resection of gliomas than dexamethasone.Furthermore,adverse reactions during the treatment should be actively prevented.
    • 李丹; 骆志国
    • 摘要: Objective To investigate the effects of cochlear implantation combined with subtotal resection of temporal bone in treatment of nasopharyngeal carcinoma after radiotherapy of temporal bone necrosis. Methods A prospective study method was used, and 76 cases of nasopharyngeal carcinoma after radiotherapy of temporal bone necrosis from February 2013 to October 2015 in our hospital for diagnosis and treatment were selected. According to the open control paired principle,the patients were equally divided into observation group and control group, each of 38 cases. Both groups received subtotal temporal bone resection in the treatment, and the observation group received cochlear implant therapy. The surgical effect and hearing improvement of two groups were observed. Results All patients successfully completed surgery. In the observation group, the patients showed normal reactions to intraoperative electrode detection and postoperative electrode impedance, without electrode slippage. There were no statistical differences between the two groups in postoperative pneumothorax and other complication (P>0.05). The sound intensity level of hearing test in postoperative 1 month in the observation group and control group were (21.23±5.22) dB and (28.42±4.19) dB, which was significantly lower than that in the preoperative 1d [(38.24 ±4.98) dB and (38.12 ±5.00) dB], with significantly statistical difference (P0.05).观察组与对照组术后1个月的听力测试声音强度分别为(21.23±5.22)dB和(28.42±4.19)dB,均低于术前1天[(38.24±4.98)dB和(38.12±5.00)dB],组内与组间比较差异均有统计学意义(均P<0.05).观察组术后1个月听觉与言语评分分别为(87.24±2.98)分和(82.10±3.91)分,均高于对照组术后1个月的(73.02±5.30)分和(71.84±3.11)分(P<0.05);观察组术前1天分别为(34.29±3.49)分、(32.10±5.30)分,对照组术前1天分别为(33.20±4.14)分、(31.98±4.92)分,两组术后1个月的听觉与言语评分亦均高于术前1天(均P<0.05).结论 鼻咽癌放疗后颞骨骨坏死患者颞骨次全切除配合人工耳蜗成功率与安全性都比较高,能促进听力与言语能力的改善,可广泛应用于临床.
    • 李雅茹
    • 摘要: 目的:通过对1例甲状腺肿行甲状腺次全切除术治疗患者围手术期的护理及临床护理效果的研究,为甲状腺肿患者的护理工作提供理论及操作参考依据。方法对我科1例甲状腺肿患者的临床资料进行回顾性分析。通过对患者采取术前护理、心理护理、饮食护理、术后护理、病情监测护理等各项护理措施,评价患者治疗以及护理效果。结果该患者经相应的治疗以及护理后,治愈出院。结论给予患者充分的术前准备、术后护理、心理护理、系统的整体护理以及并发症的预防等是甲状腺肿患者术后康复的关键。
    • 杜桂清
    • 摘要: 目的:为有效改善患者甲状腺肿胀,临床对甲状腺全切除、次全切除的治疗效果进行观察。方法选取我院2014.2———2015.6期间96例经诊断为双侧结节性甲状腺肿患者,分为比照组和治疗组,按入院时间进行分配,每组48例。比照组行甲状腺次全切除,治疗组对病患进行甲状腺全切除。观察两组出血量、手术耗时、住院时间,统计术后并发症情况。结果治疗组较对照组出血量多、手术较为耗时短,P <0.05,两组住院时间比较差别无意义,P >0.05;治疗组疾病复发、甲状旁腺损伤、神经损伤情况较对照组好,P <0.05,对照组较治疗组甲状腺功能损伤小,P <0.05。结论甲状腺全切患者疾病复发少,但对人体损伤大,部分切除人体损伤小,但疾病复发率较高,临床在治疗时可根据患者病情以及身体等各方面因素选择治疗方法。
  • 查看更多

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号